Established in 2015, Somerset Therapeutics is a privately owned pharmaceutical company that develops, manufactures, and markets generic injectable and ophthalmic drugs.
Somerset Therapeutics has had over 20 generic drug products approved and commercialized in the market. The company has over 25 product approvals pending FDA review and several additional products in development.
The company’s management team has considerable career accomplishments:
Somerset is affiliated with Odin Pharmaceuticals, a development company which specializes in difficult-to-develop and difficult-to-manufacture sterile injectable and sterile ophthalmic products.